J Arribas

Trastuzumab (herceptin), a humanized anti-Her2 receptor monoclonal antibody, inhibits basal and activated Her2 ectodomain cleavage in breast cancer cells.

J. Baselga, F. Rojo, J. Albanell, 2001, Cancer research.